ANNOUNCEMENT

MD Medical Group Investments PLC announces that the general meeting of the Company held on 23rd May, 2014 authorised the Board of Directors of the Company (the “Board of Directors”) to acquire up to a maximum of 400.000 Global Depository Receipts (“GDRs”) listed on the London Stock Exchange representing interests in ordinary shares of U.S.$0.08 each in the Company, either by private agreement or from the market (the “Buyback Programme”).

The Buyback Programme is valid between 23rd May, 2014 and 22nd May, 2015 and the purchase price of each GDR which may be acquired by the Company shall be not more than U.S.$10 and not less than U.S.$5. The period of retention by the Company of the GDRS which may be acquired by the Company pursuant to the Buyback programme may not exceed two years from the date of acquisition of the relevant GDRs.

The Board of Directors has decided to start implementing the Buyback Programme as from 9th June, 2014.